New-Concept Chemotherapy by Nanoparticles of Biodegradable Polymers: Where Are We Now?
Cites (223)
Items 201–223 of 223
- Noninvasive imaging for monitoring of viable cancer cells using a dual-imaging reporter gene.Jae Hoon Shin, June-Key Chung, Joo Hyun Kang · 2004 · PubMed
- Physical Properties and Stability Mechanisms of Poly(Ethylene Glycol) Conjugated Liposome Encapsulated Hemoglobin DispersionsDian R. Arifin, Andre Francis Palmer · 2005 · Artificial Cells Blood Substitutes and Biotechnology
- Nystatin LF (Aronex/Abbott).S. Arıkan, John H. Rex · 2001 · PubMed
- Paclitaxel encapsulated in cationic lipid complexes (MBT-0206) impairs functional tumor vascular properties as detected by dynamic contrast enhanced magnetic resonance imagingMartin Eichhorn, Sven Becker, Sebastian Strieth, Alexander Werner, Birgitta Sauer, Michael Teifel, H. Ruhstorfer, Uwe Michaelis, Jürgen Griebel, Gunnar Brix et al. · 2006 · Cancer Biology & Therapy
- Role of liposomal anthracyclines in the treatment of multiple myelomaMohamad A. Hussein, Kenneth Carl Anderson · 2004 · Seminars in Oncology
- Glucuronate-Modified, Long-Circulating Liposomes for the Delivery of Anticancer AgentsNaoto Oku, Yukihiro Namba · 2005 · Methods in enzymology on CD-ROM/Methods in enzymology
- Phase�I clinical and pharmacological study of intraperitoneal cis-bis-neodecanoato(trans-R, R-1, 2-diaminocyclohexane)-platinum�II entrapped in multilamellar liposome vesiclesClaire F. Verschraegen, S. Kumagai, R. Davidson · 2003 · Journal of Cancer Research and Clinical Oncology
- Biodegradable polymers: An updateAriella Shikanov, Neeraj Kumar, Abraham Jacob Domb · 2005 · Israel Journal of Chemistry
- Clinical and pharmacokinetic phase II study of pegylated liposomal doxorubicin and vinorelbine in heavily pretreated recurrent ovarian carcinomaDionysios Katsaros, Maria Vittoria Oletti, Irene A. Rigault de la Longrais · 2005 · Annals of Oncology
- Specific binding of sterically stabilized anti-B-cell immunoliposomes and cytotoxicity of entrapped doxorubicinBo B. Lundberg, Gary L. Griffiths, Hans J. Hansen · 2000 · International Journal of Pharmaceutics
- Cellular pharmacology of liposomal cis-bis-neodecanoato-trans-R,R-1,2-diaminocyclohexaneplatinum(II) in A2780/S and A2780/PDD cells.Insook Han, Yi He Ling, Salaam Al-Baker · 1993 · PubMed
- Prolonged schedule of temozolomide (Temodal) plus liposomal doxorubicin (Caelyx) in advanced solid cancersAhmad Hussein Awada, Thierry Gil, François Salès · 2004 · Anti-Cancer Drugs
- Identification of the serum factor required for liposome-primed activation of mouse peritoneal macrophages. Modified alpha 2-macroglobulin enhances Fc gamma receptor-mediated phagocytosis of opsonized sheep red blood cells.M. Murai, Yukihiko Aramaki, Satoshi Tsuchiya · 1995 · PubMed
- Distal Cationic Poly(Ethylene Glycol) Lipid Conjugates in Large Unilamellar Vesicles Prepared by Extrusion Enhance Liposomal Cellular UptakeTao Chen, Lorne Palmer, David B. Fenske · 2004 · Journal of Liposome Research
- Liposomalized Oligopeptides in Cancer TherapyTomohiro Asai, Naoto Oku · 2005 · Methods in enzymology on CD-ROM/Methods in enzymology
- Conformations of Polymers Attached to an InterfacePierre Gilles de Gennes · 2003 · WORLD SCIENTIFIC eBooks
- Vincristine Liposomal - INEX&NA; · 2004 · Drugs in R&D
- Fluorescent Opsonization Assay: Binding of Plasma Fibronectin to Fibrin-Derivatized Fluorescent Particles Does Not Enhance Their Uptake by MacrophagesDomenick J. Falcone · 1986 · Journal of Leukocyte Biology
- Cancer therapies crisis in the USAAntonio J Grillo-López · 2003 · Expert Review of Anticancer Therapy
- Prof. Tait on Geological TimeP. W. STUART MENTEATH · 1871 · Nature
- Phase I and pharmacokinetic (PK) study of STEALTH liposomal CKD-602 (S-CKD602) in patients with advanced solid tumorsWilliam C. Zamboni, S. Ramalingam, David Friedland · 2005 · Journal of Clinical Oncology
- Pharmacogenomic and pharmacokinetic assessment of liposome encapsulated SN-38 (LE-SN38) in advanced cancer patientsEric H. Kraut, Mayer Fishman, Patricia Mucci LoRusso · 2004 · Journal of Clinical Oncology
- Nystatin - Liposomal&NA; · 1999 · Drugs in R&D